These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. Lower protein expression levels of MHC class I chain-related gene A in hepatocellular carcinoma are at high risk of recurrence after surgical resection. Huang CF; Wang SC; Chang WT; Yeh ML; Huang CI; Lin ZY; Chen SC; Chuang WL; Huang JF; Dai CY; Chen YL; Yu ML Sci Rep; 2018 Oct; 8(1):15821. PubMed ID: 30361527 [TBL] [Abstract][Full Text] [Related]
51. Diversity of the association of serum levels and genetic variants of MHC class I polypeptide-related chain A with liver fibrosis in chronic hepatitis C. Huang CF; Huang CI; Yeh ML; Wang SC; Chen KY; Ko YM; Lin CC; Tsai YS; Tsai PC; Lin ZY; Chen SC; Dai CY; Huang JF; Chuang WL; Yu ML Oncotarget; 2017 May; 8(20):32618-32625. PubMed ID: 28427234 [TBL] [Abstract][Full Text] [Related]
52. Transcriptome-wide association study for persistent hepatitis B virus infection and related hepatocellular carcinoma. Han J; Chen C; Wang C; Qin N; Huang M; Ma Z; Zhu M; Dai J; Jiang Y; Ma H; Jin G; Shen H; Hu Z Liver Int; 2020 Sep; 40(9):2117-2127. PubMed ID: 32574393 [TBL] [Abstract][Full Text] [Related]
53. Aflatoxin B Chu YJ; Yang HI; Wu HC; Lee MH; Liu J; Wang LY; Lu SN; Jen CL; You SL; Santella RM; Chen CJ Eur J Cancer; 2018 May; 94():37-46. PubMed ID: 29533866 [TBL] [Abstract][Full Text] [Related]
54. Understanding the host genetics of chronic hepatitis B and C. Thursz M; Yee L; Khakoo S Semin Liver Dis; 2011 May; 31(2):115-27. PubMed ID: 21538279 [TBL] [Abstract][Full Text] [Related]
55. Independent and additive effects of PNPLA3 and TM6SF2 polymorphisms on the development of non-B, non-C hepatocellular carcinoma. Raksayot M; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Treeprasertsuk S; Poovorawan Y; Tanaka Y; Tangkijvanich P J Gastroenterol; 2019 May; 54(5):427-436. PubMed ID: 30506232 [TBL] [Abstract][Full Text] [Related]
56. GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers. Li S; Qian J; Yang Y; Zhao W; Dai J; Bei JX; Foo JN; McLaren PJ; Li Z; Yang J; Shen F; Liu L; Yang J; Li S; Pan S; Wang Y; Li W; Zhai X; Zhou B; Shi L; Chen X; Chu M; Yan Y; Wang J; Cheng S; Shen J; Jia W; Liu J; Yang J; Wen Z; Li A; Zhang Y; Zhang G; Luo X; Qin H; Chen M; Wang H; Jin L; Lin D; Shen H; He L; de Bakker PI; Wang H; Zeng YX; Wu M; Hu Z; Shi Y; Liu J; Zhou W PLoS Genet; 2012; 8(7):e1002791. PubMed ID: 22807686 [TBL] [Abstract][Full Text] [Related]
58. Gene polymorphisms of interleukin 28B and the risk to chronic hepatitis B virus infection in Thai. Kimkong I; Chankaew J; Kunanopparat A; Hirankarn N; Tangkijvanich P Tissue Antigens; 2015 Mar; 85(3):177-81. PubMed ID: 25664396 [TBL] [Abstract][Full Text] [Related]
59. Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study. Abbas E; Shaker O; Abd El Aziz G; Ramadan H; Esmat G Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):458-63. PubMed ID: 22293333 [TBL] [Abstract][Full Text] [Related]
60. The haplotype block, NFKBIL1-ATP6V1G2-BAT1-MICB-MICA, within the class III-class I boundary region of the human major histocompatibility complex may control susceptibility to hepatitis C virus-associated dilated cardiomyopathy. Shichi D; Kikkawa EF; Ota M; Katsuyama Y; Kimura A; Matsumori A; Kulski JK; Naruse TK; Inoko H Tissue Antigens; 2005 Sep; 66(3):200-8. PubMed ID: 16101831 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]